AI Platform for Fatigue and Depression Detection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorBrijesh Patel
About this trial
This observational study evaluates the accuracy of the Okaya AI platform in detecting fatigue and depression in cardiology patients, comparing its assessments to PHQ-9 and Fatigue Assessment Scale scores.
Eligibility criteria
Qualifiers
Age ≥18, English-speaking, able to consent
Disqualifiers
Active substance use, nonverbal, cognitive disability, active suicidal/homicidal ideation
Trial design
Treatments tested in this trial
- Participants will complete PHQ-9, FAS, and Okaya assessments.
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov